in pictures and a few words
What it is and why it matters
Coffee is one of the most studied things for health. A cup holds more than a thousand active substances, and caffeine is only one of them.
- Moderate coffee is linked to benefits for the heart, blood vessels and metabolism
- What matters is how much, when and which coffee you drink
How many cups a day
For most adults, 2–4 cups of filtered coffee a day, in the first half of the day, works best. One cup is 240 ml, about 80–100 mg of caffeine.
- No coffee at all does worse than 2–3 cups
- More than 6 cups a day — the benefit is lost, and blood pressure and anxiety rise
Heart, sugar and blood vessels
People who drink 2–4 cups a day less often get type 2 diabetes and stroke and less often die of heart disease.
- Coffee substances help keep blood sugar lower after meals
- They also act as protection for the inner wall of blood vessels
- Depression and Parkinson’s disease are also less common
A steady heartbeat
People with atrial fibrillation — a glitch where the heart beats unevenly — used to be told to quit coffee. Now we see that moderate coffee is linked to a lower risk of this glitch.
- This holds at 1–3 cups a day
- At 5 cups or more this protection disappears
- If you already have attacks, your limit may be 1–2 cups: keep a diary for 4 weeks
The benefit is not only caffeine
Most of the benefit for the heart does not come from caffeine. So it stays in coffee without caffeine too — decaf.
- Decaf is just as linked to lower risk of type 2 diabetes, stroke and death from any cause
- It suits people with anxiety, poor sleep and during pregnancy
- Regular coffee wakes you up more, and it is more strongly linked to brain protection
Paper filter and cholesterol
Unfiltered coffee contains substances that raise “bad” cholesterol. A paper filter holds back most of them.
- Filtered: drip coffee maker, pour-over cone, AeroPress with a paper filter
- Unfiltered: French press, espresso, Turkish coffee, moka pot
- With high cholesterol, switching from espresso to filter may lower it in 6–8 weeks
How and when to drink
Best 1.5–2 hours after waking up. If you are sensitive to caffeine — no later than 14:00; with insomnia — no later than 12:00.
- With gastritis or heartburn — not on an empty stomach, but with food
- Sugar is the main enemy of the benefit; with insulin problems drink it without sugar
- Milk is fine: the benefit is a little smaller, but it stays
Coffee and blood pressure
Caffeine raises blood pressure for 1–3 hours. In people who drink coffee regularly, this effect weakens.
- Pressure controlled on treatment and coffee is tolerated normally — no need to quit
- Pressure above 140/90 on three or more medicines — a 2-week trial break from caffeine
Who should see a doctor first
Here coffee is limited or stopped, and the dose is chosen individually.
- Atrial fibrillation attacks — a diary of attacks and caffeine for 4 weeks
- Pregnancy — no more than 200 mg of caffeine a day (about 1 cup of 240 ml)
- Anxiety, panic attacks — less coffee or decaf
Important. Also: insomnia, reflux or ulcer, familial polyposis, a long interval on the ECG, pressure above 140/90 on three medicines, “bad” cholesterol above 190 mg/dl.
In one sentence
2–4 cups of filtered coffee in the first half of the day is the best routine for most adults. If coffee bothers you — decaf, not giving it up completely.
Key points
Coffee is the most studied nutraceutical on the planet (more than 36 000 peer-reviewed papers); the optimum is 2–4 cups of filtered coffee per day, in the first half of the day, and this is what such intake is linked to.
| Situation | How it helps | What human studies showed |
|---|---|---|
| Heart and blood vessels | dose-dependent cardioprotection; chlorogenic acids act as antioxidants on the endothelium, the inner lining of blood vessels | in meta-analyses, 2–4 cups/day are linked to 15% lower CV mortality |
| All-cause mortality | lowest at 2–4 cups per day | the optimum, at which all-cause mortality decreases the most, is 2–4 cups per day (Poole R, BMJ 2017, PMID 29167102; Ding M, Circulation 2014, PMID 24201300); people who drink no coffee have 8% higher all-cause mortality than those drinking 2–3 cups/day |
| Type 2 diabetes | chlorogenic acids reduce post-meal glucose and increase insulin sensitivity | T2D risk 25% lower at 2–4 cups and 8% lower at 1 cup/day |
| Stroke | — | risk 20% lower at 2–4 cups/day |
| Heart rhythm (atrial fibrillation, AFib) | at the population level, the anti-inflammatory and insulin-sensitizing effects of coffee outweigh the direct adrenergic stimulus | in the UK Biobank population cohort, 1–3 cups/day meant 4–8% lower AFib risk than no coffee (Chieng D, Eur J Prev Cardiol 2022, PMID 36162818) |
| Brain and mood | neuroprotection; it is stronger with regular coffee than with decaf | at 2–4 cups/day, depression risk 20% lower and Parkinson’s disease risk 30% lower |
| Cholesterol | a paper filter retains 80–95% of the diterpenes that raise LDL; switching from espresso to filtered coffee at the same caffeine dose can reduce LDL by 8–14 mg/dL over 6–8 weeks | — |
| Decaf | retains chlorogenic acids, trigonelline, and melanoidins | in large cohorts, not inferior to regular coffee in reducing the risk of T2D, stroke, and all-cause mortality (Grosso G, Eur J Epidemiol 2016, PMID 27699514) |
How it helps
What is in the cup and how each substance helps
A cup of coffee contains more than 1 000 biologically active molecules, and caffeine is only one of them. That is why the benefit of coffee is not mediated by caffeine alone.
- Chlorogenic acids are the largest class of polyphenols in coffee. They reduce postprandial (post-meal) glucose, inhibit α-glucosidase, increase insulin sensitivity, and act as antioxidants on the endothelium.
- Trigonelline is an alkaloid that is partially converted into nicotinic acid (niacin) during roasting. It has a neuroprotective profile and improves the lipid profile.
- Melanoidins are products of the Maillard reaction during roasting. They are antioxidants, microbiota modulators, and may reduce the glycemic response.
- Caffeine is an antagonist of A1/A2A adenosine receptors. Part of the benefit of regular coffee works through it: alertness and cognitive function, and, at the population level, additional protection against AFib and stronger neuroprotection against Parkinson’s and Alzheimer’s disease.
How many cups: the U-shaped curve
Meta-analyses consistently show the same, U-shaped curve. The optimum, at which all-cause mortality decreases the most, is 2–4 cups of filtered coffee per day, in the first half of the day (Poole R, BMJ 2017, PMID 29167102; Ding M, Circulation 2014, PMID 24201300).
- 2–4 cups/day — 15% lower CV mortality, 25% lower T2D risk, 20% lower stroke risk, 20% lower depression risk, 30% lower Parkinson’s disease risk.
- 1 cup/day — 5% lower CV mortality, 8% lower T2D risk.
- 0 cups/day — 8% higher all-cause mortality versus 2–3 cups/day.
- 5 cups/day — cardioprotection plateaus; the risk of AFib and sleep disturbances begins to rise in sensitive individuals.
- >6 cups/day — higher BP, AFib triggering in predisposed individuals, sleep disorders, increased anxiety; protection against T2D and all-cause mortality is lost.
Steady rhythm: moderate coffee is linked to lower AFib risk
For many decades, coffee was considered proarrhythmic, and patients with paroxysmal AFib were advised to stop it completely. Modern data require this view to be revised.
In a large population cohort from UK Biobank (Chieng D, Eur J Prev Cardiol 2022, PMID 36162818), moderate coffee consumption reduced AFib risk by 4–8% compared with zero consumption. The effect persisted for 1–3 cups/day and disappeared at ≥5 cups/day.
The explanation: at the population level, the anti-inflammatory and insulin-sensitizing effects of coffee outweigh the direct adrenergic stimulus. Therefore, the general recommendation to “stop coffee for everyone with AFib” is outdated; how to find your own dose with paroxysmal AFib is described in “Who should see a doctor first”.
Decaf: most of the benefit without caffeine
Decaf is not “second class.” It retains chlorogenic acids, trigonelline, and melanoidins, so most of its cardioprotection remains: in large cohorts, decaf is not inferior to regular coffee in reducing the risk of T2D, stroke, and all-cause mortality (Grosso G, Eur J Epidemiol 2016, PMID 27699514).
- Decaf — reduces the risk of T2D, stroke, liver events, cirrhosis, and all-cause mortality; for these outcomes, it is not inferior to regular coffee. It is suitable for anxiety disorder, sleep disturbances, paroxysmal AFib (after testing), and pregnant women (>200 mg caffeine/day is not recommended).
- Regular coffee — the same effects plus additional protection against AFib at the population level, stronger neuroprotection against Parkinson’s and Alzheimer’s disease (at the population level), and a more pronounced effect on alertness and cognitive function.
If coffee interferes (anxiety, AFib, insomnia), switch to decaf rather than stopping completely. The decaffeination method matters: the Swiss water process and the CO2 process do not leave organic solvents. Methylene chloride decaf is an outdated method and is now rarely found on the packaging of reputable producers.
Filtered coffee protects your cholesterol
Diterpenes (cafestol and kahweol) are found in unfiltered coffee and, with regular consumption, raise LDL and total cholesterol by 5–18%. A paper filter retains 80–95% of them.
- Filtered — drip coffee maker with a paper filter, V60, Chemex, AeroPress with a paper filter. Diterpenes are minimal.
- Unfiltered — French press, espresso, Turkish coffee, Scandinavian boiled coffee, moka pot, AeroPress with a metal filter. Diterpenes pass through fully.
For a patient with dyslipidemia or a family history of CAD, switching from espresso to filtered coffee at the same caffeine dose can reduce LDL by 8–14 mg/dL over 6–8 weeks. This is comparable to the effect of 5 g of soluble fiber per day.
How to drink it
Dose
- 2–4 cups of filtered coffee/day — the optimum for most adults.
- 1–2 cups — for slow caffeine metabolizers (CYP1A2 1F/1F genotype), older adults, and pregnant women (≤200 mg/day).
- Decaf without restriction in the absence of GI disorders.
A cup is 240 mL of coffee brewed from 8–10 g of ground beans, ~80–100 mg of caffeine; espresso 30 mL = 60–80 mg of caffeine. This is convenient for calculating the daily dose.
Timing
- 90–120 minutes after waking — the natural morning cortisol peak occurs 30–60 minutes after waking. Caffeine at this time masks the physiological rhythm and reduces adenosine receptor sensitivity. If intake is shifted to 1.5–2 hours after waking, caffeine is more effective at the same dose.
- No later than 14:00 if sensitive — the half-life of caffeine is 5–6 hours. By 22:00, 25% of the morning dose is still in the blood, which is enough to impair sleep architecture in slow CYP1A2 metabolizers.
- Not on an empty stomach in gastritis/GERD — coffee stimulates HCl secretion and relaxes the lower esophageal sphincter; on an empty stomach it provokes exacerbation. Tolerability is better with food: changing the timing or taking it with food solves 80% of cases.
What to add and what not to add
- Cinnamon, cardamom, cocoa — polyphenol synergy, additional insulin sensitization.
- Milk or plant-based milk — reduces the bioavailability of chlorogenic acids by approximately 10%, but does not eliminate the benefit. If you prefer it, drink it with milk.
- Sugar and syrups — the main factor that neutralizes the benefit. 2 spoons of sugar turn a cup of coffee into a source of 12 g of simple carbohydrates. If insulin resistance is present, avoid sugar.
- MCT oil — a working option for a ketogenic diet, but not for a general diet.
Nutraceutical partners
- L-theanine 100–200 mg — partially offsets caffeine-induced anxiety while preserving the cognitive boost. Green tea contains it naturally.
- Magnesium (glycinate) 200–400 mg in the evening — compensates for the diuretic effect of caffeine.
- B vitamins — caffeine accelerates their excretion with regular consumption.
What does not replace coffee
- Energy drinks — taurine + sugar + 200 mg caffeine without polyphenols. There is no cardioprotection, and the risk of arrhythmias and BP elevation increases.
- “Bulletproof” — coffee with butter and MCT in large doses — increases morning caloric intake without proven benefit for most people; acceptable for a keto diet.
- Instant coffee as the basis of intake — contains fewer chlorogenic acids than bean coffee and often more acrylamides (a Maillard reaction product from over-roasting). Not forbidden, but not the preferred choice.
Who should see a doctor first
Here coffee is limited or stopped, and the regimen is chosen individually:
- Paroxysmal AFib — individual trigger threshold; diary for 4 weeks.
- Pregnancy — ≤200 mg caffeine/day (about 2 cups of espresso or 1 cup of 240 mL coffee).
- Resistant hypertension — trial discontinuation for 2 weeks for assessment.
- Chronic anxiety disorder, panic attacks — reduction or decaf.
- Insomnia, sleep architecture disturbances — last cup no later than 12:00.
- Active GERD or peptic ulcer disease — with food, not on an empty stomach, consider decaf.
- Familial polyposis/long QT syndrome — individually with a cardiologist.
- Dyslipidemia with LDL >190 mg/dL — switch to filtered coffee.
Paroxysmal AFib
In an individual patient with paroxysmal AFib, the individual trigger threshold may be low — 1–2 cups, so monitoring personal triggers is mandatory. Practical approach: a diary of episodes and caffeine intake (including tea and dark chocolate) for at least 4 weeks. If a correlation is found — reduction or discontinuation. If not — moderate consumption is acceptable.
Blood pressure
Caffeine is a direct cardiostimulant: it acutely raises BP by 5–10 mmHg systolic and 3–7 mmHg diastolic for 1–3 hours after intake. Chronic consumers develop partial tolerance, and 24-hour average BP increases less — by 1–4 mmHg.
This is clinically significant for resistant hypertension (BP >140/90 while taking three or more antihypertensive medications). In these patients, a trial discontinuation of caffeine for 2 weeks with BP measurement before and after is reasonable. A reduction in average BP by 5+ mmHg is a basis for permanent restriction.
In patients with controlled hypertension on therapy and a normal response to coffee, restriction is not indicated: a ban “for all hypertensive patients” is an outdated template.
Bottom line
Coffee is a nutraceutical with dose-dependent cardioprotection. The goal is 2–4 cups of filtered coffee in the first half of the day, with individual adjustment according to genotype, sleep, and cardiovascular status. For most people, complete discontinuation means losing a working tool without replacement. Decaf is a practical alternative for anxiety, AFib, or pregnancy. Unfiltered brewing methods should be reconsidered in dyslipidemia.
If coffee works for you, drink it correctly. If not, there is a way to adapt the regimen rather than giving it up completely. I perform personalized assessment of coffee intake patterns, taking into account metabolism genetics (CYP1A2), cortisol level, sleep architecture, and cardiovascular profile.
Sources
▸Ding M, Bhupathiraju SN, Satija A, et al. Long-term coffee consumption and risk of cardiovascular disease. Circulation 2014;129:643–659. PMID 24201300 ▸Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses. BMJ 2017;359:j5024. PMID 29167102 ▸Chieng D, Canovas R, Segan L, et al. The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality. Eur J Prev Cardiol 2022;29:2240–2249. PMID 36162818 ▸Grosso G, Godos J, Galvano F, et al. Coffee, caffeine, and health outcomes: an umbrella review. Eur J Epidemiol 2016;31:1191–1205. PMID 27699514 ▸Cornelis MC, El-Sohemy A. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006;295:1135–1141. PMID 16522833
Related articles: Endothelium: the foundation of vascular health, Cholesterol without statins.
Key facts
- The optimum is 2–4 cups of filtered coffee per day, in the first half of the day: at this dose all-cause mortality decreases the most (Poole R, BMJ 2017; Ding M, Circulation 2014).
- In meta-analyses, 2–4 cups/day are linked to 15% lower CV mortality, 25% lower T2D risk, 20% lower stroke risk, and 30% lower Parkinson’s risk.
- In the UK Biobank cohort, AFib risk at 1–3 cups/day was 4–8% lower than in people who drank no coffee.
- Decaf retains chlorogenic acids, trigonelline, and melanoidins and, in large cohorts, is not inferior to regular coffee in reducing the risk of T2D, stroke, and all-cause mortality.
- Paper filters retain 80–95% of diterpenes; switching from espresso to filtered coffee can lower LDL by 8–14 mg/dL over 6–8 weeks. One cup = 240 mL, ≈80–100 mg caffeine.




